Several forms of energy restriction can help people with obesity and type 2 diabetes to lose weight and manage their blood ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

A new study comparing three popular diets—intermittent fasting, time-restricted eating, and continuous calorie cutting—found ...

This week's exercise is a perfect addition for someone on a GLP-1 prescription, because it addresses another element of ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA approval is expected in 2026.

Gastrointestinal issues are common in patients taking GLP-1 weight loss drugs like Ozempic and Wegovy, but there are some lesser known side effects that range from bothersome to bizarre.

Tirzepatide is more effective than semaglutide for weight loss, according to a new study on GLP-1 medications ; The study was funded by Eli Lilly, the pharmaceutical company that manufactures ...

Using a similar study design to STEP 1, STEP 3 added IBT with a calorie-restricted diet, starting at 1000 to 1200 calories for the first 8 weeks, followed by 1200 to 1800 calories for the ...

METHODOLOGY: GLP-1 RAs are transforming obesity treatment, but high costs and shortages limit patient access. Clinicians have suggested a less frequent dosing to maintain weight loss, but evidence ...

One study he cites in the book showed that 40% of the weight loss in patients on once-a-week injections of semaglutide came from lean body mass. And about a third of that was muscle.